Subscribe to magazine
Subscribe to newsletters
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Radiation Dose management
Intravascular imaging systems
Peripheral Artery Disease
Cardiac resynchronization therapy devices (CRT)
Implantable cardioverter defibrillators (ICD)
Leads, implantable devices
Heart Valve Technology
Left atrial appendage (LAA) occluders
Structural heart occluders/closure devices
University of Colorado Hospital
Henry Ford Hospital
Baylor Scott and White Heart Hospital
BridgePoint Medical Inc.
2800 Campus Drive, #50
Plymouth, MN 55441
Chronic Total Occlusion (CTO)
September 20, 2012
Boston Scientific to Acquire CTO Catheter Company BridgePoint Medical
September 20, 2012 — Boston Scientific Corp. has signed a definitive agreement to acquire BridgePoint Medical Inc., a...
March 19, 2012
| Mark Michael, M.D., and Jeffrey A. Breall, M.D., Ph.D.
When to Consider Revascularization of Coronary Chronic Total Occlusions
Management of coronary
chronic total occlusion (CTO)
January 25, 2012
Crossboss CTO Catheter, Sapien, Watchman Among Picks for Best Cardiac Devices of 2011
January 25, 2012 — Which Medical Device announced the winner of its Device of the Year Award 2011 in the cardiology...
January 20, 2012
BridgePoint Licensing CTO Peripheral Vascular Products to Covidien
January 20, 2012 - BridgePoint Medical Inc. this week signed an agreement with Covidien to exclusively license the...
August 05, 2011
First Patient Enrolled in Trial of Peripheral Chronic Total Occlusion Device
August 5, 2011 — BridgePoint Medical Inc., a Minnesota-based medical device company, has enrolled its first patient in...
May 19, 2011
FDA Expands Indication for CrossBoss, Stingray to Treat CTOs
May 19, 2011 - BridgePoint Medical Inc. has announced that they have received clearance of an expanded indication for...
October 05, 2010
Final FDA Review Requested for Coronary CTO Crossing Catheters
October 5, 2010 – A U.S. clinical study evaluating the CrossBoss and Stingray catheters in treating chronically...
The CrossBoss and Stingray CTO catheters.
November 24, 2009
Chronic Total Occlusion Catheter System Cleared in Europe
November 24, 2009 – European CE mark clearance was granted this week for BridgePoint Medical’s coronary and peripheral...
March 13, 2009
BridgePoint Medical Completes First U.S. Clinical Case Using CrossBoss, Stingray Devices in CTO Procedure
March 13, 2009 - BridgePoint Medical Inc. completed the first human clinical case in the U.S. using its CrossBoss CTO...
Scranton Gillette Communications
. All Rights Reserved.
Topics We Cover
Terms and Conditions